Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Lung cancer, Non small cell lung cancer (NSCLC)
Closed
Phase 3
This trial is looking at the combination of olaparib and pembrolizumab for non small cell lung cancer that has spread.
Non small cell lung cancer that has spread is called advanced non small cell lung cancer.
Recruitment start: 9 December 2019
Recruitment end: 29 April 2021
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Shobhit Baijal
Merck Sharp & Dohme Ltd
Last reviewed: 2 May 2021
CRUK internal database number: 16682
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
